A New Approach To Restoring Cardiac Health
Currently, the only major treatment for heart failure is transplantation. However, it is estimated that less than 30% of patients survive long enough to receive their new hearts. The local cell death following myocardial infarction plays a major role in the progression of cardiac dysfunction.
Dr. Mike Davis' research team at Emory University School of Medicine focuses on various aspects of cardiac regeneration and preservation. His team (part of the joint Biomedical Engineering program at Emory and Georgia Institute of Technology) uses molecular based and biomaterials-based approaches to restore function after cardiac injury.